Biological tuners to reshape the bile acid pool for therapeutic purposes in non-alcoholic fatty liver disease.
- 2023-01
- Clinical science (London, England : 1979) 137(1)
- Justine Gillard
- Isabelle A Leclercq
- PubMed: 36601783
- DOI: 10.1042/cs20220697
Bile acids synthesized within the hepatocytes are transformed by gut microorganisms and reabsorbed into the portal circulation. During their enterohepatic cycling, bile acids act as signaling molecules by interacting with receptors to regulate pathways involved in many physiological processes. The bile acid pool, composed of a variety of bile acid species, has been shown to be altered in diseases, hence contributing to disease pathogenesis. Thus, understanding the changes in bile acid pool size and composition in pathological processes will help to elaborate effective pharmacological treatments. Five crucial steps along the enterohepatic cycle shape the bile acid pool size and composition, offering five possible targets for therapeutic intervention. In this review, we provide an insight on the strategies to modulate the bile acid pool, and then we discuss the potential benefits in non-alcoholic fatty liver disease.
Research Insights
| Supplement | Health Outcome | Effect Type | Effect Size |
|---|---|---|---|
| Lactobacillus salivarius UCC118 | Improved Gut Health | Beneficial | Small |
| Lactobacillus salivarius UCC118 | No Reported Health Outcome | Neutral | Small |